The weekly litigation news digest is live. Subscribe now

IP Verse

Takeda Pharmaceuticals competitive analysis

Loading summary...

Latest oppositions filed by Takeda Pharmaceuticals

Explore patent oppositions filed by Takeda Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Dec 4, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3481415
Stable Liquid FibrinogenLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESJun 5, 2024
EP3071596
Improved Process For The Preparation Of Immunoglobulin G (Igg)BIO PRODUCTS LABORATORYMay 29, 2019
EP2345425
Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive IggsLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESApr 11, 2019

Latest PTAB cases involving Takeda Pharmaceuticals

Discover the latest PTAB cases involving Takeda Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Takeda Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 4, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TAKEDA PHARMACEUTICALS3 - - -
BIO PRODUCTS LABORATORY - 1 - -
LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES - 10 - -
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES SOCIETE ANONYME - 2 - -